rs199573401
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The NM_001387283.1(SMARCA4):c.862C>G(p.Pro288Ala) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.00000137 in 1,460,796 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P288S) has been classified as Uncertain significance.
Frequency
Consequence
NM_001387283.1 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- Coffin-Siris syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Illumina
- intellectual disability, autosomal dominant 16Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- rhabdoid tumor predisposition syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- uterine corpus sarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- familial rhabdoid tumorInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary nonpolyposis colon cancerInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SMARCA4 | NM_001387283.1 | c.862C>G | p.Pro288Ala | missense_variant, splice_region_variant | Exon 6 of 36 | ENST00000646693.2 | NP_001374212.1 | |
| SMARCA4 | NM_003072.5 | c.862C>G | p.Pro288Ala | missense_variant, splice_region_variant | Exon 6 of 35 | ENST00000344626.10 | NP_003063.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SMARCA4 | ENST00000646693.2 | c.862C>G | p.Pro288Ala | missense_variant, splice_region_variant | Exon 6 of 36 | NM_001387283.1 | ENSP00000495368.1 | |||
| SMARCA4 | ENST00000344626.10 | c.862C>G | p.Pro288Ala | missense_variant, splice_region_variant | Exon 6 of 35 | 1 | NM_003072.5 | ENSP00000343896.4 | ||
| SMARCA4 | ENST00000643549.1 | c.862C>G | p.Pro288Ala | missense_variant, splice_region_variant | Exon 6 of 35 | ENSP00000493975.1 | ||||
| SMARCA4 | ENST00000541122.6 | c.862C>G | p.Pro288Ala | missense_variant, splice_region_variant | Exon 7 of 35 | 5 | ENSP00000445036.2 | |||
| SMARCA4 | ENST00000643296.1 | c.862C>G | p.Pro288Ala | missense_variant, splice_region_variant | Exon 6 of 34 | ENSP00000496635.1 | ||||
| SMARCA4 | ENST00000644737.1 | c.862C>G | p.Pro288Ala | missense_variant, splice_region_variant | Exon 6 of 34 | ENSP00000495548.1 | ||||
| SMARCA4 | ENST00000589677.5 | c.862C>G | p.Pro288Ala | missense_variant, splice_region_variant | Exon 7 of 35 | 5 | ENSP00000464778.1 | |||
| SMARCA4 | ENST00000643995.1 | c.274C>G | p.Pro92Ala | missense_variant, splice_region_variant | Exon 3 of 32 | ENSP00000496004.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000414 AC: 1AN: 241654 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1460796Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 726712 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Rhabdoid tumor predisposition syndrome 2 Uncertain:1
This sequence change replaces proline, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 288 of the SMARCA4 protein (p.Pro288Ala). This variant is present in population databases (rs199573401, gnomAD 0.001%). This variant has not been reported in the literature in individuals affected with SMARCA4-related conditions. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at